Efficacy News and Research

RSS
CAR T cells expressing a natural RNA can activate the body’s own T cells against solid tumors

CAR T cells expressing a natural RNA can activate the body’s own T cells against solid tumors

Lack of information or misconceptions affect support for long-term disaster preparedness

Lack of information or misconceptions affect support for long-term disaster preparedness

Booster shot of Pfizer COVID-19 vaccine provides additional protection against SARS-CoV-2 infection

Booster shot of Pfizer COVID-19 vaccine provides additional protection against SARS-CoV-2 infection

Rheumatoid arthritis drug plus standard of care may reduce COVID-19 mortality for hospitalized patients

Rheumatoid arthritis drug plus standard of care may reduce COVID-19 mortality for hospitalized patients

First-in-human trial proves feasibility of Temporally Feathered Radiation Therapy

First-in-human trial proves feasibility of Temporally Feathered Radiation Therapy

Can barrier gestures be relaxed without causing a COVID-19 resurgence in France?

Can barrier gestures be relaxed without causing a COVID-19 resurgence in France?

Modified R-CODOX-M/IVAC regimen shows promise for treating sporadic Burkitt lymphoma

Modified R-CODOX-M/IVAC regimen shows promise for treating sporadic Burkitt lymphoma

New review looks at the bottlenecks and breakthroughs in cancer immunotherapy

New review looks at the bottlenecks and breakthroughs in cancer immunotherapy

Increased transmissibility drives SARS-CoV-2 variant spread, aided by immune escape

Increased transmissibility drives SARS-CoV-2 variant spread, aided by immune escape

Development of SARS-CoV-2 antibody escape variants in an immunocompromised individual

Development of SARS-CoV-2 antibody escape variants in an immunocompromised individual

Does SARS-CoV-2 infection protect against reinfection?

Does SARS-CoV-2 infection protect against reinfection?

$1.3 million in NIH funding to enable drug delivery technology research

$1.3 million in NIH funding to enable drug delivery technology research

mRNA COVID-19 vaccines induce high antibody titers with significant neutralizing potency in saliva

mRNA COVID-19 vaccines induce high antibody titers with significant neutralizing potency in saliva

Post-infection vaccination produces potent neutralizing antibodies against SARS-CoV-2 variants

Post-infection vaccination produces potent neutralizing antibodies against SARS-CoV-2 variants

Investigational vaccine does not provide sufficient protection against HIV infection

Investigational vaccine does not provide sufficient protection against HIV infection

J&J COVID-19 booster shot produces robust antibody response

J&J COVID-19 booster shot produces robust antibody response

Researchers develop adult lung organoids that represent all cell types

Researchers develop adult lung organoids that represent all cell types

The tale of mRNA vaccines: Turning calamity into opportunity

The tale of mRNA vaccines: Turning calamity into opportunity

New compounds offer a two-for-one punch to fight estrogen-sensitive breast cancer

New compounds offer a two-for-one punch to fight estrogen-sensitive breast cancer

Durability of cellular immune memory to SARS-CoV-2 after mRNA vaccination

Durability of cellular immune memory to SARS-CoV-2 after mRNA vaccination

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.